Register Login

Kiniksa Pharmaceuticals (KNSA)

Ragosa Mark 🟡 adjusted position in 42.8K shares (3 derivative) of Kiniksa Pharmaceuticals International, plc (KNSA) at $41.49 ($2.7M) Transaction Date: Dec 08, 2025 | Filing ID: 000007

Full text
Register to leave comments
  • News bot Dec. 10, 2025, 10:12 p.m.

    🔍 Ragosa Mark (Executive)

    Company: Kiniksa Pharmaceuticals International, plc (KNSA)

    Report Date: 2025-12-08

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 42,841
    • Total shares sold: 85,682

    Detailed Transactions and Holdings:

    • Acquired 16,164 shares of Class A Ordinary Share at $11.1 per share (Direct)
      Date: 2025-12-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 47,250.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 16,165 shares of Class A Ordinary Share at $11.97 per share (Direct)
      Date: 2025-12-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 63,415.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 10,512 shares of Class A Ordinary Share at $10.76 per share (Direct)
      Date: 2025-12-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 73,927.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 42,841 shares of Class A Ordinary Share at $41.49 per share (Direct)
      Date: 2025-12-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 31,086.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 16,164 shares of Share Option at $11.1 per share (Derivative)
      Date: 2025-12-08 | Code: M | Expires: 2032-04-06 | equity_swap_involved: 0 | shares_owned_after: 5,388.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 16,165 shares of Share Option at $11.97 per share (Derivative)
      Date: 2025-12-08 | Code: M | Expires: 2032-08-31 | equity_swap_involved: 0 | shares_owned_after: 12,123.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 10,512 shares of Share Option at $10.76 per share (Derivative)
      Date: 2025-12-08 | Code: M | Expires: 2033-03-31 | equity_swap_involved: 0 | shares_owned_after: 14,016.00 | transaction_form_type: 4 | Footnotes: F1, F5

    Footnotes:

    • F1: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.
    • F2: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $41.20 and $42.08. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
    • F3: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022.
    • F4: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022.
    • F5: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2023.

Search

News categories